Skip to content

Efficacy of Kashmaryadi Ghrita in reducing incidence of abortion

Efficacy of Kashmaryadi Ghrita in reducing the incidence of Garbhasrava (abortion) : A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012418
Enrollment
100
Registered
2018-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Married females in first trimester of pregnancy having history of 1 or more spontaneous abortions Health Condition 2: O200- Threatened abortion

Interventions

Intervention1: GROUP A ORAL KASHMARYADI GHRITA: Kashmaryadi Ghrita 12 gm in two divided doses orally in morning and evening before meals with milk for 2 months Control Intervention1: GROUP B ORAL MICR

Sponsors

INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married females in first trimester of pregnancy having history of 1 or more spontaneous abortion Pregnancy of woman confirmed by urine pregnancy test and ultrasonography

Exclusion criteria

Exclusion criteria: Women in third trimester of pregnancy Patients with severe systemic disease cardiovascular complications diabetes mellitus Diagnosed cases of disorders of reproductive tract like Tuberculosis Carcinoma Uterine fibroid Patients of incompetent os and congenital deformities of uterus Patients of STD like VDRL HIV

Design outcomes

Primary

MeasureTime frame
Trial drug will help in continuation of pregnancy and also help in growth and development of fetusTimepoint: 18 months

Secondary

MeasureTime frame
Drug may have effect in improving the minor ailments of first trimester of pregnancyTimepoint: First trimester of pregnancy

Countries

India

Contacts

Public ContactProf Laxmipriya Dei

IPGT and RA GAU Jamnagar

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026